메뉴 건너뛰기




Volumn 170, Issue 11, 2011, Pages 1471-1474

Omalizumab in the treatment of eosinophilic esophagitis and food allergy

Author keywords

Eosinophilic esophagitis; Food allergy; Latex; Omalizumab

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; DESLORATADINE; IMMUNOGLOBULIN E; MONTELUKAST; OMALIZUMAB;

EID: 82655162172     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1540-4     Document Type: Article
Times cited : (138)

References (6)
  • 1
    • 84855757149 scopus 로고    scopus 로고
    • Identifying responders to Xolair (omalizumab) using eosinophilic esophagitis as a disease model
    • Accessed 2 April 2011
    • Alpan O (2009) Identifying responders to Xolair (omalizumab) using eosinophilic esophagitis as a disease model. ClinicalTrials.gov identifier: NCT01040598. Available via http://clinicaltrials.gov. Accessed 2 April 2011
    • (2009) ClinicalTrials.gov Identifier: NCT01040598
    • Alpan, O.1
  • 2
    • 84855766592 scopus 로고    scopus 로고
    • A pilot study of the treatment of eosinophilic esophagitis with omalizumab
    • Accessed 2 April 2011
    • Fang JC (2005) A pilot study of the treatment of eosinophilic esophagitis with omalizumab. ClinicalTrials.gov identifier: NCT00123630. Available via http://clinicaltrials.gov. Accessed 2 April 2011
    • (2005) ClinicalTrials.gov Identifier: NCT00123630
    • Fang, J.C.1
  • 6
    • 56549112256 scopus 로고    scopus 로고
    • Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases
    • 19037962 10.1111/j.1365-2222.2008.03122.x 1:CAS:528: DC%2BD1MXnsV2qtA%3D%3D
    • KD Stone C Prussin 2008 Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases Clin Exp Allergy 38 12 1858 65 19037962 10.1111/j.1365-2222.2008.03122.x 1:CAS:528:DC%2BD1MXnsV2qtA%3D%3D
    • (2008) Clin Exp Allergy , vol.38 , Issue.12 , pp. 1858-65
    • Stone, K.D.1    Prussin, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.